http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1444527-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b262c842f9c7f3c38a61e1f2d892f1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-105 |
| filingDate | 1975-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1444527-A |
| titleOfInvention | Guanidine derivatives |
| abstract | 1444527 Guanidine derivatives JENAPHARM VEB 17 April 1975 [18 April 1974] 15913/75 Heading C2C Novel compounds (I) and the metal salts thereof (II) where R is alkyl, alkenyl, cycloalkyl or aryl and Men is an n-valent metal with an affinity for sulphur, e.g. Nn, Cu, Hg, Ni, Co, Cd, Ag, Pb or Bi, are made by reacting triaminoguanidine or its salt with R.NCS and, if desired, converting the product (I) obtained into its salt (II). Pharmaceutical preparations having coccidiostatic action contain (I) and/or (II) as active ingredient. Administration is orally. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1103190-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001151675-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4680339-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6379694-B1 |
| priorityDate | 1974-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.